SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 500.51 |
| Book Value / Share | 6.57 |
| Price / Book | n/a |
| NCAV ($M) | -428.64 |
| NCAV / Share | -5.63 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.56 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.78 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.25 |
| Current Ratio | 1.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 371.18 |
| Assets | 1,300.33 |
| Liabilities | 799.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 297.15 |
| Operating Income | -128.95 |
| Net Income | -657.27 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -281.95 |
| Cash from Investing | 241.59 |
| Cash from Financing | -465.06 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 379,725 | 2,170,527 | 17.49 | |
| 337,824 | 2,156,718 | 15.66 | |
| 807,667 | 5,286,741 | 15.28 | |
| 1,667,778 | 7,460,763 | 22.35 | |
| 1,611,732 | 8,327,521 | 19.35 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BPMC – Blueprint Medicines Corporation | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. |